Mario Schlosser changed role as Co-Founder & Advisor to the CEO at Oscar Health, Inc..
“Mr. Schlosser’s transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.”
Oscar Health, Inc. — fact timeline
Source-grounded facts extracted from Oscar Health, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Oscar Health, Inc. reported first quarter ended March 31, 2026 results: revenue $4,647,194, net income $678,996, EPS $2.07. Guidance reaffirmed.
“results press release dated February 10, 2026. First Quarter 2026 Financial Highlights Three Months Ended March 31, (in thousands, except percentages) 2026 2025 Total revenue $4,647,194 $3,046,263 Medical loss ratio (“MLR”) 70.5% 75.4% Selling, general, and administrative (“SG&A”) expense ratio 15.2% 15.8% Earnings from operations $704,085 $297,123 Net income”
Oscar Health, Inc. incurred revolving credit of $475.0 million with JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto at Term SOFR plus a margin of 4.50% per annum, or the Alternate Base Rate plus a ma maturing February 6, 2029.
“On February 6, 2026, Oscar Health, Inc. (the “Company”), entered into a $475.0 million secured three-year revolving credit facility (the “Revolving Credit Facility”), pursuant to a Credit Agreement (the “Credit Agreement”), by and among the Company, certain subsidiaries of the Company, as subsidiary guarantors, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto.”
Oscar Health, Inc. entered into Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto valued at $475.0 million (effective 2026-02-06).
“On February 6, 2026, Oscar Health, Inc. (the “Company”), entered into a $475.0 million secured three-year revolving credit facility (the “Revolving Credit Facility”), pursuant to a Credit Agreement (the “Credit Agreement”), by and among the Company, certain subsidiaries of the Company, as subsidiary guarantors, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto.”
Alessandrea Quane departed as EVP, Chief Insurance Officer at Oscar Health, Inc..
“Alessandrea Quane, the Company’s EVP, Chief Insurance Officer, will cease serving in this role effective as of February 24, 2025 and her employment with the Company and Oscar Management Corporation (“OMC”) will terminate effective as of March 3, 2025.”
Steven Wolin resigned as EVP and Chief Operating Officer at Oscar Health, Inc..
“Steven Wolin resigned as EVP and Chief Operating Officer of the Company, effective as of February 5, 2025.”
Janet Liang was appointed as EVP and President of Oscar Insurance at Oscar Health, Inc..
“appointed Janet Liang as EVP and President of Oscar Insurance, effective February 24, 2025.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.